Maria Krauth

Qualifications:

• Specialist in internal medicine
• Additional specialist in hematology and internal oncology
• Habilitation in internal medicine (topic of habilitation thesis: "Leukocyte function analyses as a contribution to the evaluation of the safety of conventional and targeted antineoplastic therapies in hemato-oncology")
• Emergency physician diploma
• 2-year additional training in hematological special diagnostics (cytomorphology, immunophenotyping, molecular genetics, cytogenetics, next-generation sequencing) at the MLL, Munich Leukemia Laboratory, Munich, Germany (Head: Prof. DDr. Torsten Haferlach, Prof. Dr. Wolfgang Kern, Prof.in Dr.in Susanne Schnittger, Prof.in Dr.in Claudia Haferlach)

Focus on clinical research:

• Multiple myeloma, MGUS and amyloidosis: diagnostics, therapy and development of special monitoring strategies
• Myeloproliferative syndromes, specifically: primary osteomyelofibrosis; polycythemia vera; essential thrombocytosis; diagnostics, therapy and development of prognostic factors
• Myelodysplastic/myeloproliferative overlap syndromes: diagnosis, therapy and development of prognostic factors

Focus on basic research:

• Multiple myeloma, MGUS and amyloidosis: diagnostics, therapy and development of special monitoring strategies
• Myeloproliferative syndromes, in particular: primary osteomyelofibrosis; polycythemia vera; essential thrombocytosis; diagnostics, therapy and development of prognostic factors
• Myelodysplastic/myeloproliferative overlap syndromes: diagnosis, therapy and development of prognostic factors
• Acute myeloid leukemia: diagnosis and development of prognostic factors
• Special haematological diagnostics for the identification and characterization of haematological neoplasms
• Diagnostics and targeted antineoplastic therapies in haematology

Membership of the following societies:

• Austrian Society for Hematology and Oncology (OEGHO)
• Austrian Society for Internal Medicine (OEGIM)
• European Haematology Association (EHA)
• Member of the EMN Board since October 2019: The EMN is a network of renowned experts from various European countries in the field of haematology and represents the largest European international association for multiple myeloma
• Member of the Central European Myeloproliferative Neoplasm Organization (CEMPO) and co-author of the CEMPO and Austrian Consensus/Guidelines for Myeloproliferative Diseases;
• Member of the OEGHO and DGHO as well as the scientific committees for the Onkopedia Guidelines;
• Member of the Austrian Scientific Platform for Multiple Myeloma and Amyloidosis;
• Member of the Austrian Scientific Platform for Myeloproliferative Diseases;
• Member of the International Society for Amyloidosis (ISA) ;
• Member of the International Kidney Monoclonal Gammopathy Research Group (IKMG);

https://www.myeloma-europe.org/

Functions at the Medical University of Vienna:

• Deputy head of the hematology outpatient clinic
• Program director for multiple myeloma and paraprotein-associated diseases
• Program Director for Myeloproliferative Diseases (Polycythemia Vera, Essential Thrombocytosis, Osteomyelofibrosis)
• Deputy Head of the Interdisciplinary Amyloidosis Center of the MUW/AKH (IAZ-MUW, Associated Center within EuroBloodNet, ERN Hematology)

Publications:
» PubMed Publication list